Table 2. Newborns’ Prophylaxis Effectiveness According to Mother’s Hepatitis B Statusa.
| Status | Effective | Borderline | Non-Effective | Unknown | Total |
|---|---|---|---|---|---|
| Diagnosis of hepatitis B in pregnancy | |||||
| Before pregnancy | 9 (25.7) | 9 (23.7) | |||
| First trimester | 11 (31.4) | 1 (100) | 12 (31.6) | ||
| Second trimester | 9 (25.7) | 9 (23.7) | |||
| Third trimester | 6 (17.1) | 1 (100) | 1 (100) | 8 (21.1) | |
| PCR implementation time | |||||
| First trimester | 10 (32.3) | 10 (29.4) | |||
| Second trimester | 8 (25.8) | 1 (100) | 9 (26.5) | ||
| Third trimester | 13 (41.9) | 1 (100) | 1 (100) | 15 (44.1) | |
| DNA PCR | |||||
| Positive | 25 (83.3) | 1 (100) | 1 (100) | 1 (100) | 28 (84.8) |
| Negative | 5 (16.7) | 5 (15.2) | |||
| Anti-Viral drug | |||||
| Yes | 6 (17.1) | 1 (100) | 1 (100) | 8 (21.1) | |
| No | 29 (82.9) | 1 (100) | 30 (78.9) | ||
| Beginning time of anti-viral drugs | |||||
| First trimester | 1 (16.7) | 1 (12.5) | |||
| Second trimester | 1 (16.7) | 1 (12.5) | |||
| Third trimester | 4 (66.6) | 1 (100) | 1 (100) | 6 (75) |
aValues are expressed as No.(%).